Betta Pharmaceuticals Co., Ltd. logo

Betta Pharmaceuticals Co., Ltd.

SZSE:300558.SZ

Overview | Financials
Company Name Betta Pharmaceuticals Co., Ltd.
Symbol 300558.SZ
Currency CNY
Price 56.19
Market Cap 23,514,729,239
Dividend Yield 0.17%
52-week-range 42.5 - 74.83
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Lieming Ding
Website https://www.bettapharma.com

An error occurred while fetching data.

About Betta Pharmaceuticals Co., Ltd.

Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the

Related Stocks

Dian Diagnostics Group Co.,Ltd. logo

Dian Diagnostics Group Co.,Ltd.

300244.SZ

22 CNY

Meinian Onehealth Healthcare Holdings Co., Ltd. logo

Meinian Onehealth Healthcare Holdings Co., Ltd.

002044.SZ

6.08 CNY

Winning Health Technology Group Co., Ltd. logo

Winning Health Technology Group Co., Ltd.

300253.SZ

7.38 CNY

Guangzhou Wondfo Biotech Co.,Ltd logo

Guangzhou Wondfo Biotech Co.,Ltd

300482.SZ

24.61 CNY

Dong-E-E-Jiao Co.,Ltd. logo

Dong-E-E-Jiao Co.,Ltd.

000423.SZ

45.48 CNY

Tofflon Science and Technology Group Co., Ltd. logo

Tofflon Science and Technology Group Co., Ltd.

300171.SZ

18.15 CNY

Jilin Aodong Pharmaceutical Group Co., Ltd. logo

Jilin Aodong Pharmaceutical Group Co., Ltd.

000623.SZ

16.09 CNY

PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc.

300725.SZ

39.57 CNY

Shandong Xinhua Pharmaceutical Company Limited logo

Shandong Xinhua Pharmaceutical Company Limited

000756.SZ

19.47 CNY

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. logo

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

002399.SZ

11.65 CNY

Financials

Numbers are in millions USD

Numbers are in millions USD